The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Parkinson's Disease-Global Market Insights and Sales Trends 2024
Synopsis
The global Parkinson's Disease market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Parkinson's Disease in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Parkinson's Disease market. Carbidopa/Levodopa, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dopamine Receptor Agonists segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Parkinson's Disease market, driven by demand from China, the second largest economy with some signs of stabilising, the Parkinson's Disease market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Parkinson's Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Parkinson's Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Parkinson's Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Parkinson's Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Parkinson's Disease covered in this report include Teva, Novartis, GSK, AbbVie, Merck, Boehringer Ingelheim, Amneal + Impax, Lundbeck and Sun Pharma, etc.
The global Parkinson's Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Global Parkinson's Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Parkinson's Disease market, Segment by Type:
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Global Parkinson's Disease market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Parkinson's Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Parkinson's Disease market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Parkinson's Disease in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Parkinson's Disease market. Carbidopa/Levodopa, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dopamine Receptor Agonists segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Parkinson's Disease market, driven by demand from China, the second largest economy with some signs of stabilising, the Parkinson's Disease market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Parkinson's Disease, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Parkinson's Disease market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Parkinson's Disease market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Parkinson's Disease sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Parkinson's Disease covered in this report include Teva, Novartis, GSK, AbbVie, Merck, Boehringer Ingelheim, Amneal + Impax, Lundbeck and Sun Pharma, etc.
The global Parkinson's Disease market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Amneal + Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Bausch Health
Acadia
Global Parkinson's Disease market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Parkinson's Disease market, Segment by Type:
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Global Parkinson's Disease market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Parkinson's Disease companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Parkinson's Disease
1.1 Parkinson's Disease Market Overview
1.1.1 Parkinson's Disease Product Scope
1.1.2 Parkinson's Disease Market Status and Outlook
1.2 Global Parkinson's Disease Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Parkinson's Disease Market Size by Region (2018-2029)
1.4 Global Parkinson's Disease Historic Market Size by Region (2018-2023)
1.5 Global Parkinson's Disease Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Parkinson's Disease Market Size (2018-2029)
1.6.1 North America Parkinson's Disease Market Size (2018-2029)
1.6.2 Europe Parkinson's Disease Market Size (2018-2029)
1.6.3 Asia-Pacific Parkinson's Disease Market Size (2018-2029)
1.6.4 Latin America Parkinson's Disease Market Size (2018-2029)
1.6.5 Middle East & Africa Parkinson's Disease Market Size (2018-2029)
2 Parkinson's Disease Market by Type
2.1 Introduction
2.1.1 Carbidopa/Levodopa
2.1.2 Dopamine Receptor Agonists
2.1.3 MAO-Inhibitors
2.2 Global Parkinson's Disease Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Parkinson's Disease Historic Market Size by Type (2018-2023)
2.2.2 Global Parkinson's Disease Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Parkinson's Disease Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Parkinson's Disease Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Parkinson's Disease Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Parkinson's Disease Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Parkinson's Disease Revenue Breakdown by Type (2018-2029)
3 Parkinson's Disease Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Parkinson's Disease Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Parkinson's Disease Historic Market Size by Application (2018-2023)
3.2.2 Global Parkinson's Disease Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Parkinson's Disease Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Parkinson's Disease Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Parkinson's Disease Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Parkinson's Disease Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Parkinson's Disease Revenue Breakdown by Application (2018-2029)
4 Parkinson's Disease Competition Analysis by Players
4.1 Global Parkinson's Disease Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2022)
4.3 Date of Key Players Enter into Parkinson's Disease Market
4.4 Global Top Players Parkinson's Disease Headquarters and Area Served
4.5 Key Players Parkinson's Disease Product Solution and Service
4.6 Competitive Status
4.6.1 Parkinson's Disease Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Teva
5.1.1 Teva Profile
5.1.2 Teva Main Business
5.1.3 Teva Parkinson's Disease Products, Services and Solutions
5.1.4 Teva Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.1.5 Teva Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Parkinson's Disease Products, Services and Solutions
5.2.4 Novartis Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 GSK
5.3.1 GSK Profile
5.3.2 GSK Main Business
5.3.3 GSK Parkinson's Disease Products, Services and Solutions
5.3.4 GSK Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.3.5 AbbVie Recent Developments
5.4 AbbVie
5.4.1 AbbVie Profile
5.4.2 AbbVie Main Business
5.4.3 AbbVie Parkinson's Disease Products, Services and Solutions
5.4.4 AbbVie Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.4.5 AbbVie Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Parkinson's Disease Products, Services and Solutions
5.5.4 Merck Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Profile
5.6.2 Boehringer Ingelheim Main Business
5.6.3 Boehringer Ingelheim Parkinson's Disease Products, Services and Solutions
5.6.4 Boehringer Ingelheim Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.6.5 Boehringer Ingelheim Recent Developments
5.7 Amneal + Impax
5.7.1 Amneal + Impax Profile
5.7.2 Amneal + Impax Main Business
5.7.3 Amneal + Impax Parkinson's Disease Products, Services and Solutions
5.7.4 Amneal + Impax Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.7.5 Amneal + Impax Recent Developments
5.8 Lundbeck
5.8.1 Lundbeck Profile
5.8.2 Lundbeck Main Business
5.8.3 Lundbeck Parkinson's Disease Products, Services and Solutions
5.8.4 Lundbeck Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.8.5 Lundbeck Recent Developments
5.9 Sun Pharma
5.9.1 Sun Pharma Profile
5.9.2 Sun Pharma Main Business
5.9.3 Sun Pharma Parkinson's Disease Products, Services and Solutions
5.9.4 Sun Pharma Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.9.5 Sun Pharma Recent Developments
5.10 Wockhardt
5.10.1 Wockhardt Profile
5.10.2 Wockhardt Main Business
5.10.3 Wockhardt Parkinson's Disease Products, Services and Solutions
5.10.4 Wockhardt Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.10.5 Wockhardt Recent Developments
5.11 UCB
5.11.1 UCB Profile
5.11.2 UCB Main Business
5.11.3 UCB Parkinson's Disease Products, Services and Solutions
5.11.4 UCB Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.11.5 UCB Recent Developments
5.12 Bausch Health
5.12.1 Bausch Health Profile
5.12.2 Bausch Health Main Business
5.12.3 Bausch Health Parkinson's Disease Products, Services and Solutions
5.12.4 Bausch Health Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.12.5 Bausch Health Recent Developments
5.13 Acadia
5.13.1 Acadia Profile
5.13.2 Acadia Main Business
5.13.3 Acadia Parkinson's Disease Products, Services and Solutions
5.13.4 Acadia Parkinson's Disease Revenue (US$ Million) & (2018-2023)
5.13.5 Acadia Recent Developments
6 North America
6.1 North America Parkinson's Disease Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Parkinson's Disease Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Parkinson's Disease Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Parkinson's Disease Market Dynamics
11.1 Parkinson's Disease Industry Trends
11.2 Parkinson's Disease Market Drivers
11.3 Parkinson's Disease Market Challenges
11.4 Parkinson's Disease Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
